Medicine & Health

Leaders from seven countries explored the WashU FARM initiative’s public health-driven research and global partnerships advancing sustainable, equitable food systems.

Research from WashU psychologists finds perception of neighborhood safety affects brain development.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.

Padma Gulur, MD, a physician-scientist and nationally recognized leader in pain management, has been named the head of the Department of Anesthesiology and the inaugural Alex S. Evers MD Distinguished Professor in Anesthesiology at WashU Medicine. Her appointment begins Aug. 1.

A study by researchers at WashU Medicine reveals how the body reprograms stable fat cells to eliminate stubborn fat reserves.

Researchers at WashU Medicine and Weizmann Institute of Science designed a CAR-T cell therapy that reduced amyloid beta plaques in the brains of mice, pointing to a promising new approach for Alzheimer’s disease.

Guaranteed income programs may reduce food insecurity and improve nutrition among low-income Black households in Georgia, according to a new study led by the Brown School at Washington University in St. Louis. 

A new tool developed by WashU Medicine researchers could allow for preemptive treatment of implant-related infections that improves outcomes and reduces patients’ emotional and financial burden.

A brain network first identified by WashU Medicine researchers, called SCAN, is shown in a new study to be the neurological basis for Parkinson’s disease. Patients receiving treatments targeted to this brain region, rather than to surrounding areas, experienced greater improvements in symptoms.

WashU researchers urge institutions to reward implementation science that demonstrates benefit, improves health, reduces inequities and justifies research investment.